Delivery Order SPE2DB20D2104-SPE2DB25FMTKD

Award Date 6/16/25
Potential Completion Date 6/17/25
Potential Value $1.6K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Alfuzosin HCl ER 10 mg tablets. The delivery order is valued at $2,592.98 and has a period of performance through May 8, 2025. The contract is a firm-fixed-price delivery order, with no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with the DLA...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corporation's Corporate Office division. The order is for 4,565,863,575 units of Alfuzosin HCL ER 10 mg tablets, with a ceiling value of $16,832.49. The contract has a period of performance through September 19, 2024 and uses a Firm Fixed Price pricing structure. AmerisourceBergen is a major pharmaceutical distributor that holds several Indefinite Delivery...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of Alfuzosin HCL ER 10 mg tablets. The firm-fixed-price contract has a ceiling value of $1,390.10 and a performance period through August 29, 2024. AmerisourceBergen, a major pharmaceutical distributor, will provide these prescription medications to support military treatment facilities and other federal healthcare programs. This contract award is part of a larger...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Alfuzosin HCL ER 10 mg tablets. The contract is a firm fixed price, non-set-aside award with a ceiling value of $1,466.08 and a performance period ending on April 29, 2025. Amerisourcebergen Drug Corp is the prime contractor for this delivery order, which is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of Alfuzosin HCL ER 10 mg tablets. The contract has a ceiling value of $3,756.00 and is a firm fixed-price arrangement with a completion date of August 1, 2024. AmerisourceBergen, a major pharmaceutical distributor, holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider based in Conshohocken, Pennsylvania. The contract, which is not set-aside, has a firm-fixed price of $1,225.68 and a completion date of May 22, 2025. It covers the delivery of 120 tablets of the medication Alfuzosin Hydrochloride Extended Release 10 mg. Amerisourcebergen Drug Corp holds a significant Indefinite...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp for the supply of Alfuzosin HCL ER 10 mg tablets. The order is for $3,846.82 and has a firm fixed price. The contract has an ultimate completion date of September 12, 2024. AmerisourceBergen is a major pharmaceutical distributor that holds several Indefinite Delivery Contracts (IDCs) with the DLA and other federal agencies for the provision of a wide range of...
This is a firm-fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of 1,000 units of the drug Alfuzosin HCL ER 10 mg tablet. The contract has a ceiling value of $3,548.76 and a completion date of June 12, 2025. This contract is not set aside and is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999.00 that Amerisourcebergen holds with the DLA for the global...
This contract award for $1,415.85 was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of Alfuzosin HCL ER 10 mg tablets and has an ultimate completion date of October 13, 2023. The contract is a delivery order under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $7,671.08 for the supply of 4,563,933,249 units of the prescription drug Alfuzosin HCl ER 10 mg tablets. The contract, awarded by the Defense Logistics Agency (DLA) Troop Support Medical, is a firm fixed-price, open-competition delivery order with no set-aside designation. It has an ultimate completion date of March 13, 2024. Amerisourcebergen Drug Corp holds a significant...
  • SPE2DB20D2104
    Indefinite Delivery Contract
  • SPE2DB20D2104-SPE2DB25FMTKD
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Alfuzosin HCl ER 10 mg tablets in 90-count bottles, with a ceiling value of $1,556.85 and a completion date of June 17, 2025. The contract is a firm fixed-price arrangement and does not have a set-aside designation, indicating open competition.

AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00. This prime contract, designated as SPE2DX, provides a comprehensive global pharmaceutical support vehicle with a performance period extending through December 2026. The IDC enables the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, serving customers including the Defense Health Agency and U.S. Coast Guard.

Generated 9/15/25, 9:47 AM